Swedish contract development and manufacturing organization, Recipharm, plans to acquire 74 percent of shares of Nitin Lifesciences, an Indian sterile injectables contract manufacturing organization, for $105.2 million. The deal is expected to take place during Q1 2016, following approval from the Indian Foreign Investment Promotion Board, reports BioSpectrumAsia. On...